ADO and neoplasm: The finding that the “Extracellular ATP to ADO Pathway” is significantly enhanced in MTEX relative to CEX represents another important observation, which agrees with previous reports that tumor cells producing sEV which carry intraluminal ADO and actively produce ADO are the major source of immunosuppressive ADO in cancer plasma [22, 28].